Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Saccade testing in the diagnosis and treatment of type 3 Gaucher disease.

Pensiero S, Accardo A, Pittis MG, Ciana G, Bembi B, Perissutti P.

Neurology. 2005 Dec 13;65(11):1837. No abstract available.

PMID:
16344538
2.

[Gaucher disease type I diagnosed at 63 years old presenting with thrombocytopenia].

Kawahara S, Kato A, Oshimi K, Ida H.

Rinsho Ketsueki. 2008 May;49(5):335-9. Japanese.

PMID:
18572811
3.

[Gaucher's disease--ocular manifestation and treatment].

Filipek E, Koraszewska-Matuszewska B.

Klin Oczna. 2006;108(7-9):357-60. Review. Polish.

PMID:
17290842
4.

From Bone Marrow Necrosis to Gaucher Disease; A Long Way to Run.

Erdem N, Çizmecioğlu A, Aydoğdu İ.

Turk J Haematol. 2015 Dec;32(4):373-4. doi: 10.4274/tjh.2015.0123. Epub 2015 Aug 6. No abstract available.

5.

Deterioration of the auditory brainstem response in children with type 3 Gaucher disease.

Campbell PE, Harris CM, Vellodi A.

Neurology. 2004 Jul 27;63(2):385-7.

PMID:
15277647
6.

Improvement of splenomegaly and pancytopenia by enzyme replacement therapy against type 1 Gaucher disease: a report of sibling cases.

Tsuboi K, Iida S, Kato M, Hayami Y, Hanamura I, Miura K, Harada S, Komatsu H, Banno S, Wakita A, Nitta M, Ueda R.

Int J Hematol. 2001 Apr;73(3):356-62.

PMID:
11345203
7.

Gaucher disease: progressive mesenteric and mediastinal lymphadenopathy despite enzyme therapy.

Burrow TA, Cohen MB, Bokulic R, Deutsch G, Choudhary A, Falcone RA Jr, Grabowski GA.

J Pediatr. 2007 Feb;150(2):202-6.

PMID:
17236903
8.

Evolving features in type 3 Gaucher disease on long-term enzyme replacement therapy.

Elstein D, Abrahamov A, Altarescu G, Zimran A.

Blood Cells Mol Dis. 2013 Feb;50(2):140. doi: 10.1016/j.bcmd.2012.09.008. Epub 2012 Oct 22. No abstract available.

PMID:
23085428
9.

Ocular motor abnormalities in Gaucher disease.

Harris CM, Taylor DS, Vellodi A.

Neuropediatrics. 1999 Dec;30(6):289-93.

PMID:
10706022
10.

Dose-dependent responses to macrophage-targeted glucocerebrosidase in a child with Gaucher disease.

Barton NW, Brady RO, Dambrosia JM, Doppelt SH, Hill SC, Holder CA, Mankin HJ, Murray GJ, Zirzow GC, Parker RI.

J Pediatr. 1992 Feb;120(2 Pt 1):277-80.

PMID:
1735829
11.

Enzyme replacement in Gaucher disease.

Beutler E.

PLoS Med. 2004 Nov;1(2):e21. Epub 2004 Nov 30. Review. No abstract available.

12.

Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry.

Weinreb NJ, Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, Rosenbloom BE, Scott CR, Wappner RS, Zimran A.

Am J Med. 2002 Aug 1;113(2):112-9.

PMID:
12133749
13.

Ten years' experience of enzyme infusion therapy of Norrbottnian (type 3) Gaucher disease.

Erikson A, Forsberg H, Nilsson M, Aström M, Månsson JE.

Acta Paediatr. 2006 Mar;95(3):312-7.

PMID:
16497642
14.

[Gaucher disease with multiple bone necrosis treated by enzyme replacement therapy and pamidronate].

Abe M, Minoguchi M, Jinbo J, Kikuchi Y, Chiba A, Shibata Y, Kogo Y.

Nihon Naika Gakkai Zasshi. 2004 Nov 10;93(11):2421-3. Japanese. No abstract available.

PMID:
15624481
15.

Positive heterophile antibody test and massive splenomegaly in an adolescent with previously unsuspected Gaucher disease.

Chou ST, Shah SS, Hodinka RL, Cohen AR.

Pediatr Emerg Care. 2004 Mar;20(3):181-4.

PMID:
15094578
16.

Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease.

Drelichman G, Ponce E, Basack N, Freigeiro D, Aversa L, Graciela E, Kohan R.

J Pediatr. 2007 Aug;151(2):197-201. Epub 2007 Jun 22.

PMID:
17643778
17.

Imiglucerase low-dose therapy for paediatric Gaucher disease--a long-term cohort study.

Heitner R, Arndt S, Levin JB.

S Afr Med J. 2004 Aug;94(8):647-51.

PMID:
15352589
18.

[Enzyme replacement therapy: a new treatment concept in Gaucher disease].

Beck M, Mengel E, Barone R.

Wien Klin Wochenschr. 1997 Feb 14;109(3):81-5. German.

PMID:
9139464
19.

Rebound hepatosplenomegaly in type 1 Gaucher disease.

Tóth J, Erdos M, Maródi L.

Eur J Haematol. 2003 Feb;70(2):125-8.

PMID:
12581195
20.

Gaucher disease: resetting the clinical and scientific agenda.

Mistry PK, Weinreb NJ, Brady RO, Grabowski GA.

Am J Hematol. 2009 Apr;84(4):205-7. doi: 10.1002/ajh.21384. No abstract available.

Supplemental Content

Support Center